Priority Review of Drug Submissions (Therapeutic Products) (French, HTML)

Priority Review of Drug Submissions (Therapeutic Products): French HTML file. From Health Canada, updated Sep 2023. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2023-09-03

Priority Review is a fast-track status granted to eligible new drug submissions for human use, following review and approval of a request submitted by the sponsor of the drug. Priority Review submissions are introduced into Health Canada's drug review queue in accordance with an accelerated review target of 180 days.

Access original file

Data overview

Formats
HTML
File languages
French
Available actions
Access original file

Official sources and licences

Related open data